Amunix Pharmaceuticals, Inc.
Biotechnology company · South San Francisco, California, United States
Amunix Pharmaceuticals, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. It has reported private securities offerings to the US SEC, most recently $117 million sold in a notice filed in 2021.
Profile compiled from public records. Is this your company? Request a correction or update
Amunix Pharmaceuticals at a glance
Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
SEC CIK1805035
What does Amunix Pharmaceuticals do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $117 million sold (2021).
Frequently asked questions about Amunix Pharmaceuticals
Where is Amunix Pharmaceuticals headquartered?
Amunix Pharmaceuticals, Inc. is headquartered in South San Francisco, California, United States.
What does Amunix Pharmaceuticals do?
Amunix Pharmaceuticals, Inc. is a biotechnology company.
Similar companies
- Alector, Inc.South San Francisco, California, United States
- Vaxart, Inc.South San Francisco, California, United States
- Denali Therapeutics Inc.South San Francisco, California, United States
- Aligos Therapeutics, Inc.South San Francisco, California, United States
- PROFUSA, Inc.South San Francisco, California, United States
- Quince Therapeutics, Inc.South San Francisco, California, United States
- Allogene Therapeutics, Inc.South San Francisco, California, United States
- Sutro Biopharma, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences